Join our community of smart investors

UK mid caps with reasonably priced prospects

Our screen targets fairly valued shares with expected earnings growth
UK mid caps with reasonably priced prospects

 

  • Mid caps offer more fairly valued growth choice than blue chips
  • Some sectors intuitively feel like more of a leap of faith

With the economic outlook turning sour around the world, analysts are having a tough time predicting growth for company earnings. It’s even harder to find growth at a reasonable price. The companies highlighted by our screen this month are from a selection of industries that are not guaranteed to perform well in a recessionary environment, but they reflect the strange set of circumstances we find ourselves in. 

Our UK large-cap screen sees packaging company Smurfit Kappa Group (SKG) pass 9/9 tests, but others are struggling to offer a blend of growth and value. The only other company to pass at least seven tests is Hikma Pharmaceuticals (HIK). 

To continue reading...
Subscribe to Alpha Today and You’ll Get
  • Unlimited access to all of our content
  • The Analyst's round up of companies and updates on his Fantasy Sipp portfolio
  • Broker style company research notes from our small cap expert Simon Thompson
  • Quality, Momentum, Growth at Reasonable Price (GARP) and Dividend Yield stock screens
  • Algy Hall’s monthly value-momentum investment trust screen and portfolio of diverse closed-end funds
Have an account? Sign in